BioGenerator Company Canopy Biosciences Acquired by Bruker ST. LOUIS – BioGenerator, the investment arm of BioSTL, announced today that its portfolio company, Canopy Biosciences, a commercial stage multi-omics and fluorescent […]
Read MoreA treatment for COVID-19 patients — developed in St. Louis by the team at Confluence Discovery Technologies as part of Aclaris Therapeutics — will begin human studies in a matter of […]
Read MoreSt. Louis startup aims to more quickly and affordably bring vaccines to market ST. LOUIS – With coaching from BioGenerator’s unique Grants-2-Business program, St. Louis bioscience startup VaxNewMo has earned […]
Read MoreST. LOUIS, MO (Feb. 4, 2020)—Biotech company Adarza BioSystems announced today that it has raised $25 million in a Series D round co-led by 3×5 Partners, based in Portland, Ore., […]
Read MoreIn 2019, BioGenerator, the investment arm of BioSTL, invested more than $3.2 million into 16 St. Louis pharma, agtech, medical device, and healthy-living companies. Eight of those companies earned first-time […]
Read MoreBioGenerator-supported digital health company wins $20k cash + contract Phas3, a St. Louis-based company providing remote cardiac rehab, has won Colorado’s Prime Health Challenge, which will allow Phas3 to pilot its […]
Read MoreCanopy Biosciences, a 2-year-old St. Louis company providing genomics products and services, made its second acquisition this week. Canopy announced Wednesday that it bought Core Diagnostics, a Hayward, California, provider of biomarker […]
Read MoreBioGenerator-backed company is first to manufacture digital health device in St. Louis St. Louis digital health company Readout Health is set to help millions of people manage their health through […]
Read MoreCrop Innovation Company Introduces New Seed Company Focused on High-Performance Food & Feed Grade Soybeans Growers can tap into growing markets with expanded offerings of high-quality, high-yielding varieties ST. LOUIS, […]
Read MoreST. LOUIS, Dec. 4, 2019 /PRNewswire/ — Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for biopharmaceutical researchers. With the […]
Read More